Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes

ER Whittemore, W Yang, JA Drewe and RM Woodward

CoCensys, Inc., Irvine, California 92618, USA.

The human gamma-aminobutyric acidA (GABAA) receptor alpha 4 subunit was recently cloned and characterized pharmacologically using radioligand binding techniques. These studies suggested that alpha 4 subunits confer a novel diazepam-insensitive binding site. To further investigate the pharmacology of the alpha 4 subunit, we expressed human alpha 4 beta 2 gamma 2L subunit combinations in oocytes and compared the expression and pharmacology of these receptors with alpha 1 beta 2 gamma 2L, beta 2 gamma 2L, and other possible binary subunit combinations. Apparent GABA affinity was 2-3-fold higher for alpha 4 beta 2 gamma 2L than for alpha 1 beta 2 gamma 2L receptors. Functional modulation of receptors by benzodiazepine-site ligands and other classes of allosteric modulator were assayed over a broad concentration range (0.01-100 microM) on currents that were 10% of the maximum GABA response. Diazepam (0.01-1 microM) did not modulate GABA responses at alpha 4 beta 2 gamma 2L receptors, whereas it increased alpha 1 beta 2 gamma 2L responses by approximately 110%. Bretazenil (0.01-1 microM), a benzodiazepine partial agonist, induced higher efficacy modulation of alpha 4 beta 2 gamma 2L receptors (approximately 83%) than of alpha 1 beta 2 gamma 2L (approximately 25%). The benzodiazepine antagonist flumazenil (0.1-10 microM) unexpectedly potentiated alpha 4 beta 2 gamma 2L responses up to approximately 41%, and the benzodiazepine partial inverse agonist Ro15-4513 (1 microM) potentiated alpha 4 beta 2 gamma 2L responses by approximately 63%. Two other benzodiazepine-site ligands, CGS-9895 and methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3- carboxylate, had qualitatively similar effects at alpha 1 beta 2 gamma 2L and alpha 4 beta 2 gamma 2L. Modulators such as pentobarbital, 3 alpha-hydroxy-5 alpha-pregnan-20-one, mefenamic acid, and loreclezole also induced similar potentiation at both subtypes of receptor. The pharmacology conferred by the alpha 4 subunit was similar to that conferred by the alpha 6 subunit, to which it shows highest levels of homology, but the two subunits differ in sensitivity to the beta- carboline methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate. Properties of the alpha 4-containing receptors are consistent with diazepam-insensitive binding sites found in cerebral cortex and other forebrain structures. Characterization of these receptors should further our understanding of mechanisms underlying the behavioral effects of GABA modulators and help in the design of drugs with improved, or novel, therapeutic profiles.

Volume 50, Issue 5, pp. 1364-1375, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. B. Ali and A. M. Thomson Synaptic {alpha}5 Subunit-Containing GABAA Receptors Mediate IPSPs Elicited by Dendrite-Preferring Cells in Rat Neocortex Cereb Cortex, June 1, 2008; 18(6): 1260 - 1271. [Abstract] [Full Text] [PDF]

				A. Keramidas and N. L. Harrison Agonist-dependent Single Channel Current and Gating in {alpha}4{beta}2{delta} and {alpha}1{beta}2{gamma}2S GABAA Receptors J. Gen. Physiol., January 28, 2008; 131(2): 163 - 181. [Abstract] [Full Text] [PDF]

				R. F. Yoshimura, D. J. Hogenkamp, W. Y. Li, M. B. Tran, J. D. Belluzzi, E. R. Whittemore, F. M. Leslie, and K. W. Gee Negative Allosteric Modulation of Nicotinic Acetylcholine Receptors Blocks Nicotine Self-Administration in Rats J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 907 - 915. [Abstract] [Full Text] [PDF]

				J. Wu, Y. Chang, G. Li, F. Xue, J. DeChon, K. Ellsworth, Q. Liu, K. Yang, N. Bahadroani, C. Zheng, et al. Electrophysiological Properties and Subunit Composition of GABAA Receptors in Patients With Gelastic Seizures and Hypothalamic Hamartoma J Neurophysiol, July 1, 2007; 98(1): 5 - 15. [Abstract] [Full Text] [PDF]

				H. J. Ng, E. R. Whittemore, M. B. Tran, D. J. Hogenkamp, R. S. Broide, T. B. Johnstone, L. Zheng, K. E. Stevens, and K. W. Gee Nootropic {alpha}7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators PNAS, May 8, 2007; 104(19): 8059 - 8064. [Abstract] [Full Text] [PDF]

				B. C. Drafts and J. L. Fisher Identification of Structures within GABAA Receptor {alpha} Subunits That Regulate the Agonist Action of Pentobarbital J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1094 - 1101. [Abstract] [Full Text] [PDF]

				A. J. Smith, B. Oxley, S. Malpas, G. V. Pillai, and P. B. Simpson Compounds Exhibiting Selective Efficacy for Different {beta} Subunits of Human Recombinant {gamma}-Aminobutyric AcidA Receptors J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 601 - 609. [Abstract] [Full Text] [PDF]

				B. C. Drafts and J. L. Fisher Structural Determinants of the Pharmacological Properties of the GABAA Receptor {alpha}6 Subunit J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1108 - 1115. [Abstract] [Full Text] [PDF]

				C. Leroy, P. Poisbeau, A. F. Keller, and A. Nehlig Pharmacological plasticity of GABAA receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy J. Physiol., June 1, 2004; 557(2): 473 - 487. [Abstract] [Full Text] [PDF]

				E. Sanna, M. C. Mostallino, F. Busonero, G. Talani, S. Tranquilli, M. Mameli, S. Spiga, P. Follesa, and G. Biggio Changes in GABAA Receptor Gene Expression Associated with Selective Alterations in Receptor Function and Pharmacology after Ethanol Withdrawal J. Neurosci., December 17, 2003; 23(37): 11711 - 11724. [Abstract] [Full Text] [PDF]

				C. E. Adkins, G. V. Pillai, J. Kerby, T. P. Bonnert, C. Haldon, R. M. McKernan, J. E. Gonzalez, K. Oades, P. J. Whiting, and P. B. Simpson alpha 4beta 3delta GABAA Receptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential J. Biol. Chem., October 12, 2001; 276(42): 38934 - 38939. [Abstract] [Full Text] [PDF]

				E. Fujii and S. H. Mellon Regulation of Uterine {{gamma}}-Aminobutyric AcidA Receptor Subunit Expression throughout Pregnancy Endocrinology, May 1, 2001; 142(5): 1770 - 1777. [Abstract] [Full Text]

				A. J. Smith, L. Alder, J. Silk, C. Adkins, A. E. Fletcher, T. Scales, J. Kerby, G. Marshall, K. A. Wafford, R. M. McKernan, et al. Effect of alpha Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant gamma -Aminobutyric AcidA Receptors Determined Using 36Cl Ion Flux Mol. Pharmacol., April 16, 2001; 59(5): 1108 - 1118. [Abstract] [Full Text]

				P. Follesa, M. Serra, E. Cagetti, M. G. Pisu, S. Porta, S. Floris, F. Massa, E. Sanna, and G. Biggio Allopregnanolone Synthesis in Cerebellar Granule Cells: Roles in Regulation of GABAA Receptor Expression and Function during Progesterone Treatment and Withdrawal Mol. Pharmacol., June 1, 2000; 57(6): 1262 - 1270. [Abstract] [Full Text]

				J. E. Hawkinson, M. Acosta-Burruel, K. C. Yang, D. J. Hogenkamp, J.-S. Chen, N. C. Lan, J. A. Drewe, E. R. Whittemore, R. M. Woodward, R. B. Carter, et al. Substituted 3beta -Phenylethynyl Derivatives of 3alpha -Hydroxy-5alpha -pregnan-20-one: Remarkably Potent Neuroactive Steroid Modulators of gamma -Aminobutyric AcidA Receptors J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 198 - 207. [Abstract] [Full Text]

				D. Belelli, J. J. Lambert, J. A. Peters, K. Wafford, and P. J. Whiting The interaction of the general anesthetic etomidate with the gamma -aminobutyric acid type A receptor is influenced by a single amino acid PNAS, September 30, 1997; 94(20): 11031 - 11036. [Abstract] [Full Text] [PDF]

				J. Amin, A. Brooks-Kayal, and D. S. Weiss Two Tyrosine Residues on the alpha  Subunit Are Crucial for Benzodiazepine Binding and Allosteric Modulation of gamma -Aminobutyric AcidA Receptors Mol. Pharmacol., May 1, 1997; 51(5): 833 - 841. [Abstract] [Full Text]